体外循环与炎性肺损伤
被引量:6
Lung inflammatory injury after cardiopulmonary bypass
摘要
体外循环 (CPB)可诱发全身性炎症反应综合征 (SIRS)。本文重点阐述了
Cardiopulmonary bypass(CPB) can induce systemic inflammatory response syndrome(SIRS). This review elaborated the influences of SIRS in acute lung injury after CPB.
出处
《医学研究生学报》
CAS
2001年第2期164-168,共5页
Journal of Medical Postgraduates
关键词
体外循环
全身炎症反应综合征
肺损伤
Cardiopulmonary bypass
Systemic inflammatory response syndrome
Lung injury
参考文献34
-
1Albelda SM,Smith CW,Ward PA.Adhesion molecules and inflammatory injury[J].FASEB J,1994,8:504-512.
-
2Friedman M,Wang SY,Franklin A,et al.Pulmonary injury after total partial cardiopulmonary bypass with thromboxane synthesis inhibition[J].Ann Thorac Surg,1995,59:598-603.
-
3Kubes P,Ibbotson G,Russell J,et al.Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence[J].Am J Physiol,1990,259:G300-305.
-
4Sawa Y,Schaper J,Roth M,et al.Platelet-activating factor plays an important role in reperfusion injury in myocardium:efficacy of platelet-activating factor receptor antagonist(CV-3988) as compared with leukocyte-depleted reperfusion[J].Ann Thorac Cardiovasc Surg,1994,108:953-959.
-
5Zehr KJ,Poston RS,Lee PC,et al.Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass[J].Ann Thorac Surg,1995,59:328-35.
-
6Jansen NJG,van Oeveren W,Gu YJ,et al.Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass[J].Ann Thorac Surg,1992,54:744-748.
-
7Stenberg JB,Kapelanski DP,Olson JD,et al.Cytokine and complement levels in patients undergoing cardiopulmonary bypass[J].J Thorac Cardiovasc Surg,1993,106:1008-1016.
-
8Wakefield TW,Kirsh MM,Till GO,et al.Absence of complement-mediated events after protamine reversal of heparin anticoagulation[J].J Surg Res,1991,51:72-76.
-
9Seghaye MC,Duchateau J,Grabitz RG,et al.Complement activation during cardiopulmonary bypass in infants and children:relation to postoperative multiple system organ failure[J].J Thorac Cardiovasc Surg,1993,106:978-987.
-
10Cave AC,Manche A,Derias NW,et al.Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit[J].J Thorac Cardiovasc Surg,1993,106:959-967.
同被引文献74
-
1许艳荣,徐凯智,卢家凯,卿恩明.异丙酚对体外循环肺损伤的保护作用[J].中国体外循环杂志,2006,4(3):131-134. 被引量:5
-
2Sievers HH,Ferund KC, Eleftheriadis S, et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion; preliminary results of a novel perfusion strategy. AnnThorac Surg,2002,74: 1167-1172.
-
3[2]Lodge AJ. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglet: timing of dose is important[J]. J Thoracic Cardiovascular Surg,1999,117(3):515-522.
-
4[3]Lord RA, Roath OS, Thompson JF et al. Effect of aprotinin on neutrophil function after major vascular surgery[J]. Br J Surg,1992,79(3):517-521.
-
5[4]Boldt J, Osmer C, Schindler E et al. Circulation adhension molecules in cardiac operations: influence of high doze aprotinin[J]. Ann Thoracic Surg, 1995,59(1):100-105.
-
6[5]Carrier M, Khalil A, Tourigny A et al. Effect of L-arginine on metabolic recovery of the ischemic myocardium[J]. Ann Thorac Surg ,1996,61(8):1651-1657.
-
7[6]Videm V, Svennevig J, Fosse E et al. Reduced complement activation with heparin-coated oxygenator and tubing in coronary bypass operations[J]. J Thorac Cardiovascular Surg ,1992,103(4):806-813.
-
8[7]Hiyama A, Takeda J, Kotate Y et al. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass[J]. J Cardiothorac Vasc Anesth ,1997,11(3):580-584.
-
9[8]Yamazaki T,Ooshima H,Usui A et al. Protective effects of ONO-5046*Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury[J]. Ann Thoracic Surg,1999,68(7):2141-2146.
-
10[9]Chenoweth DE. Complement activation produced by biomaterials[J]. Trans Am Soc Artif Intern Organs, 1986,32: 226-232.
引证文献6
-
1胡建明,章晔,王荣胜,林庆,刘志芳,陈艰.丹参氧合血肺动脉持续灌注对先天性心脏病合并肺动脉高压患儿体外循环手术中的肺保护作用[J].实用临床医学(江西),2008,9(8):43-46. 被引量:2
-
2任新英,陈春玲,王江.心肺转流肺动脉持续灌注氧合血的肺保护作用[J].临床麻醉学杂志,2009,25(10):866-867. 被引量:1
-
3王和枚,丁日高,阮金秀.急性肺损伤的中性粒细胞作用机制研究进展[J].中国工业医学杂志,2002,15(6):348-352. 被引量:10
-
4钱建军,景华,李忠东,胡小南,董国华,王常田,罗立国,顾卫东.体外循环患者心肌炎症活性的改变[J].医学研究生学报,2003,16(9):670-673. 被引量:1
-
5王常田,景华,李忠东,胡小南,董国华,罗立国,顾卫东,申翼,许飚,钱建军.基质金属蛋白酶-9在体外循环肺损伤中作用的初步研究[J].医学研究生学报,2003,16(5):361-364. 被引量:21
-
6黄戈,李忠东,景华.体外循环与肺保护[J].医学研究生学报,2004,17(3):273-275. 被引量:2
二级引证文献37
-
1申翼,张宝仁,景华.基质金属蛋白酶-9与体外循环肺损伤[J].医学研究生学报,2004,17(10):925-928.
-
2黄慧,徐作军.CXC趋化因子在急性肺损伤中的作用[J].国外医学(呼吸系统分册),2005,25(7):489-492. 被引量:2
-
3任斌辉,景华,李德闽,李忠东,罗立国,申翼,顾卫东,许飚,易俊.乌司他丁减轻体外循环肺损伤的临床研究[J].实用医学杂志,2005,21(15):1700-1701. 被引量:8
-
4赵黎丽,徐道妙,覃军.异氟醚预处理对犬体外循环肺损伤的保护作用[J].中南大学学报(医学版),2005,30(5):620-620.
-
5胡小南,景华,李忠东,董国华,张利东,王波.部分左心室减容手术后的监护治疗[J].医学研究生学报,2005,18(12):1142-1142. 被引量:2
-
6余崇林,孙蔚亮,秦大莲.TNF-α在重症胰腺炎大鼠肺组织内的表达及与肺损伤关系的实验研究[J].解剖与临床,2006,11(1):24-27. 被引量:4
-
7邹宗望,潘琴,冯竞,徐建国,向道康.体外循环心脏手术中联合应用乌司他丁和抑肽酶对肺的保护作用[J].新医学,2006,37(3):176-178. 被引量:2
-
8王明海,张义胜,赵国海,史海生,蒋勇,陶坤,韩光峰,吴敬医.实验性大鼠重症急性胰腺炎早期肺组织中MDA、MPO的变化[J].皖南医学院学报,2006,25(2):81-83. 被引量:11
-
9易俊,景华,朱家全,董国华,许飚,罗立国,顾卫东.心脏瓣膜置换术后肾功能改变的临床分析[J].医学研究生学报,2006,19(7):603-606. 被引量:11
-
10邵志华,王和枚,陈嘉斌,朱晓新,赵建,张天宏,黄春倩,张宪成,候廷奎,孙晓红,徐进,丁日高,阮金秀.清开灵注射液对小鼠全氟异丁烯吸入性急性肺水肿的治疗作用[J].中国职业医学,2006,33(4):241-244. 被引量:4
-
1仇万山,景华,李德闽,李忠东,胡小南.体外循环炎性肺损伤预警指标初探[J].江苏医药,2002,28(9):687-689.
-
2于洋,高铭鑫,李海涛,张帆,白辰,顾承雄.肺动脉灌注抗肿瘤坏死因子-α抗体减轻体外循环的肺损伤[J].中国胸心血管外科临床杂志,2013,20(6):698-704. 被引量:2
-
3高铭鑫,李海涛,张帆,白辰,于洋.肺灌注抗肿瘤坏死因子抗体对体外循环肺超微结构的影响[J].中华胸心血管外科杂志,2014,30(1):33-37. 被引量:1